SpaDerma Enhances Patient Experience with New Laser Technology
Introducing OMNI™ Laser Hair Removal at SpaDerma
Palo Alto, California — Sciton Inc., recognized for its leadership in aesthetic technology, has partnered with SpaDerma, a top-tier medical spa group in Chicago. SpaDerma has now integrated 12 OMNI™ laser hair removal systems at its locations, signifying a major enhancement in its service offerings.
Since its inception in 2000, SpaDerma has gained recognition for its combination of innovative technology and a focus on patient care. This commitment has allowed SpaDerma to expand across five practices in the Chicago area, providing advanced aesthetic treatments designed to make patients feel and look their best. Thousands of individuals seek out SpaDerma each month, benefiting from sophisticated treatments ranging from laser therapies to injectables and holistic wellness services.
The Commitment to Quality and Trust
For CEO Louis Gelman, choosing the OMNI was a significant decision rooted in trust and experience. "Initially, we lacked all the comprehensive technical specifications of OMNI, but we were confident in our Sciton representative's assurances regarding its potential. Our previous engagements with Sciton’s products had always been positive, which made committing to this new technology straightforward," stated Gelman. He expressed that the OMNI has surpassed their expectations in speed, effectiveness, and reliability.
Sciton's dedication to supporting its clients is a standout aspect, according to Gelman. One of SpaDerma's leading estheticians had the privilege of previewing the OMNI device before its release.
"Upon her return, she enthusiastically confirmed, 'This is it.' The technology offered everything we sought, reinforcing our decision to adopt this system early," Gelman recounted.
Revolutionizing Laser Hair Removal
OMNI provides a new level of efficiency, comfort, and versatility in laser hair removal. This system is powerful, featuring up to 5000 W of energy output, a large spot size, and versatile wavelengths including 760 nm, as well as blends of 810/940 nm, 940 nm Vascular, and 1060 nm. These enhancements enable SpaDerma to deliver quicker treatments while maintaining high standards of comfort and effectiveness for patients.
The staff at SpaDerma have already perceived a remarkable difference in patient experiences.
"We are even contemplating reducing appointment durations due to its efficiency, and our patients are thrilled with the results they achieve," remarked Gelman.
The Importance of Innovation and Collaboration
Sciton's Marketing Director, Michael Keith, commended SpaDerma's dedication to quality and the established trust with its clientele. "We appreciate SpaDerma’s commitment to providing excellent care and believe they embody the type of partner we aim to support with our technologies. They are clinical-focused and results-oriented, dedicated to delivering outstanding patient outcomes," said Keith.
The OMNI system adds to Sciton's impressive lineup of award-winning solutions, which also includes advanced technologies like HALO® TRIBRID™ and BBL® HEROic™, reinforcing the company's aim of improving lives through innovation.
About SpaDerma and Sciton
SpaDerma, established in 2000, stands as Chicago's leading destination for top-notch medical aesthetic treatments. With five facilities, the spa is celebrated for its skilled team of practitioners and a results-driven philosophy regarding treatments. Their extensive services encompass a variety of laser and light-based treatments, injectables, chemical peels, microneedling, wellness therapies, and weight management.
Sciton, headquartered in Palo Alto, California, is an employee-owned medical device company that has been at the forefront of aesthetic technology since 1997. Founded by industry innovators James Hobart, PhD, and Daniel K. Negus, PhD, Sciton produces quality solutions for medical and aesthetic applications, improving practices and patient satisfaction. With a global footprint in over 45 countries, Sciton continues to redefine standards in aesthetic and medical excellence.
Frequently Asked Questions
What is the OMNI™ laser hair removal system?
The OMNI™ laser hair removal system is a cutting-edge technology from Sciton that enhances the efficiency and comfort of hair removal treatments.
Why did SpaDerma choose the OMNI system?
SpaDerma chose the OMNI system due to their trust in Sciton's technology and the positive experiences they had with previous equipment.
How does OMNI improve laser hair removal treatments?
OMNI offers improved efficiency, higher comfort levels, and versatility across various treatment needs, allowing faster sessions with excellent patient outcomes.
What services does SpaDerma offer?
SpaDerma provides a wide range of aesthetic treatments including laser therapies, injectables, peels, microneedling, as well as wellness services.
Where is SpaDerma located?
SpaDerma has five locations throughout the Chicago area, making it accessible for patients seeking advanced aesthetic treatments.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.